neurogesx inc (NGSX:OTC US)
Keith R. Bley Ph.D.
Senior Vice President of Nonclinical Research & Development, NeurogesX, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Dr. Keith R. Bley, PhD has been the Senior Vice President of Product Development at NovaBay Pharmaceuticals, Inc. since March 4, 2013. Dr. Bley joined NovaBay Pharmaceuticals, Inc. in March 4, 2013. Dr. Bley has more than 20 years experience in the pharmaceutical industry with increasingly responsible management positions in research and product development. He served as consultant to various pharmaceutical companies in the Bay Area and assisted these companies with ...
2215 Bridgepointe ParkwayPhone: 650-358-3300
San Mateo, California 94404
Board Members Memberships*There is no Board Members Memberships data available.
Catholic University of America
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Daniel N. Swisher Jr.||Chief Executive Officer, President and Director|
Sunesis Pharmaceuticals, Inc.
|John R. Plachetka Pharm D.||Co-Founder, Chairman, Chief Executive Officer and President|
|$591.9K||Compensation as of Fiscal Year 2013.|